ReviewInternational journal of nanomedicine2025
Bioactive Nanomaterials: Comprehensive Monitoring and Regulation of Acute Pancreatitis Induced Acute Lung Injury.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- A Synthesis of the Best Evidence for Rhubarb Administration in the Treatment of Acute Pancreatitis in China.Journal of multidisciplinary healthcare · 2026Review
- Oxidative stress in acute pancreatitis induced acute lung injury: mechanisms and therapeutic advances.PeerJ · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mounting evidence suggests acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a complication of acute pancreatitis (AP), a disorder associated with several health challenges, a common cause of multiple organ damage, and a contributing factor to mortality. The exact mechanism behind the disorder has not been fully understood over the years, although what is mostly known is that the intensity of the AP in turn plays a significant role in the state of the ALI/ARDS. The eradicative role via conventional/pharmacological intervention has caused only little impact over the years. However, the nanotechnological advancement over the years may set the stage for ameliorating the condition. This review seeks to expound on the possible potential embedded with bioactive nanomaterials tackling the limitations faced by conventional drugs by highlighting AP and its associated ALI/ARDS, the nanotechnological role in the face of the loopholes of the conventional intervention, and the use of bioactive nanomaterials ranging from anti-inflammatory to anti-oxidant for the modulation ALI/ARDS. In addition, other modulating effects of bioactive-nanoparticles, the application of nanocomposite/hybrid nanoparticles and the conclusion and future perspective encompassing the cytotoxic effect and other concerns. In all, understanding the mechanisms and the bioactive nanomaterials potential roles may create a platform that can be of potential clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.